News
-
Protein Modeling, Cell Imaging and Patient-Powered Science: Reflections on Biohub’s Start to the Year
Co-founder Priscilla Chan shares reflections following Aspen Ideas: Health on the models, tools, and people driving Biohub's progress this year.
-
Surprising drug targets for psoriasis emerge from comprehensive CRISPR study of human skin cells
Analysis of results by AI ‘novelty filter’ led researchers to formulate topical gels that, in mice, were as effective as widely used injected therapy.
-
Biology’s blind spot
Inflammation drives nearly every major disease, yet we’ve never been able to directly watch it progress in living tissue. These researchers are building the technologies to change that.
-
The Scientist: Three amino acids improve lipid nanoparticle therapy delivery to cells
-
Simple ‘Cocktail’ of Amino Acids Dramatically Boosts Power of Anti-Inflammatory mRNA Therapies and CRISPR Gene Editing
Adding three common amino acids to lipid nanoparticle injections increased mRNA delivery up to 20-fold, pushed gene editing efficiency to nearly 90%, and suppressed inflammation in a model of acute liver disease.
-
Shana Kelley: 5 new ways to measure inflammation
With AI-integrated platforms to watch immune cells in action, we will be able to intervene in inflammation before it becomes disease, says Biohub’s president of bioengineering.
-
Axios: Zuckerberg and Chan bet AI can cure all disease
-
Associated Press: Zuckerberg, Chan shift bulk of philanthropy to science, focusing on AI and biology to curb disease
-
Latent Space: Priscilla Chan and Mark Zuckerberg — Frontier AI + virtual biology to solve all diseases
-
a16z Podcast: Mark Zuckerberg & Priscilla Chan — How AI will cure all disease
-
Biohub launches first large-scale scientific initiative combining frontier AI with frontier biology to cure or prevent disease
Biohub to unite data, compute, experimental science, and AI to transform and accelerate scientific research.
-
An update from our founders
We're going all in on AI-powered biology for our next chapter.